Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...